These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 31227287)

  • 21. Association between changes in serum bone metabolism markers and bone microarchitecture changes during basic combat training - The ARMI study.
    Coulombe JC; Bozzini BN; Guerriere KI; Foulis SA; Reynoso M; Walker LA; Staab JS; Bouxsein ML; Hughes JM; Popp KL
    Bone; 2024 Dec; 189():117241. PubMed ID: 39182596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Use of CTX-I and PINP as bone turnover markers: National Bone Health Alliance recommendations to standardize sample handling and patient preparation to reduce pre-analytical variability].
    Szulc P; Naylor K; Pickering ME; Hoyle N; Eastell R; Leary E
    Ann Biol Clin (Paris); 2018 Aug; 76(4):373-391. PubMed ID: 30078776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Effect of Caloric Restriction with and without n-3 PUFA Supplementation on Bone Turnover Markers in Blood of Subjects with Abdominal Obesity: A Randomized Placebo-Controlled Trial.
    Razny U; Goralska J; Calder PC; Gruca A; Childs CE; Kapusta M; Slowinska-Solnica K; Dembinska-Kiec A; Solnica B; Malczewska-Malec M
    Nutrients; 2021 Sep; 13(9):. PubMed ID: 34578973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
    Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
    Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone turnover markers are associated with higher cortical porosity, thinner cortices, and larger size of the proximal femur and non-vertebral fractures.
    Shigdel R; Osima M; Ahmed LA; Joakimsen RM; Eriksen EF; Zebaze R; Bjørnerem Å
    Bone; 2015 Dec; 81():1-6. PubMed ID: 26112819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with the oral growth hormone secretagogue MK-677 increases markers of bone formation and bone resorption in obese young males.
    Svensson J; Ohlsson C; Jansson JO; Murphy G; Wyss D; Krupa D; Cerchio K; Polvino W; Gertz B; Baylink D; Mohan S; Bengtsson BA
    J Bone Miner Res; 1998 Jul; 13(7):1158-66. PubMed ID: 9661080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Collagen-related markers of bone turnover reflect the severity of liver fibrosis in patients with primary biliary cirrhosis.
    Guañabens N; Parés A; Alvarez L; Martínez de Osaba MJ; Monegal A; Peris P; Ballesta AM; Rodés J
    J Bone Miner Res; 1998 Apr; 13(4):731-8. PubMed ID: 9580479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in Collagen Type I C-Telopeptide and Procollagen Type I N-Terminal Propeptide During the Menopause Transition.
    Shieh A; Karlamangla AS; Gossiel F; Eastell R; Greendale GA
    J Clin Endocrinol Metab; 2024 May; 109(6):1580-1589. PubMed ID: 38087944
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reference intervals of β-C-terminal telopeptide of type I collagen, procollagen type I N-terminal propeptide and osteocalcin for very elderly Chinese men.
    Shou Z; Jin X; Bian P; Li X; Chen J
    Geriatr Gerontol Int; 2017 May; 17(5):773-778. PubMed ID: 27137883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
    Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low Bone Turnover Markers in Young and Middle-Aged Male Patients with Type 2 Diabetes Mellitus.
    Liu XX; Jiang L; Liu Q; Zhang J; Niu W; Liu J; Zhang Q
    J Diabetes Res; 2020; 2020():6191468. PubMed ID: 32851096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dimethandrolone Undecanoate, a Novel, Nonaromatizable Androgen, Increases P1NP in Healthy Men Over 28 Days.
    Thirumalai A; Yuen F; Amory JK; Hoofnagle AN; Swerdloff RS; Liu PY; Long JE; Blithe DL; Wang C; Page ST
    J Clin Endocrinol Metab; 2021 Jan; 106(1):e171-e181. PubMed ID: 33090208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role for bone turnover markers β-CrossLaps (CTX) and amino-terminal propeptide of type I collagen (PINP) as potential indicators for disease progression from MGUS to multiple myeloma.
    Vallet S; Hoyle NR; Kyle RA; Podar K; Pecherstorfer M
    Leuk Lymphoma; 2018 Oct; 59(10):2431-2438. PubMed ID: 29345175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial.
    Berger PK; Pollock NK; Laing EM; Chertin V; Bernard PJ; Grider A; Shapses SA; Ding KH; Isales CM; Lewis RD
    J Nutr; 2015 Dec; 145(12):2699-704. PubMed ID: 26491117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biochemical markers of bone turnover after surgical menopause and hormone replacement therapy.
    Peris P; Alvarez L; Monegal A; Guañabens N; Durán M; Pons F; Martínez de Osaba MJ; Echevarría M; Ballesta AM; Muñoz-Gómez J
    Bone; 1999 Sep; 25(3):349-53. PubMed ID: 10495139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a growth hormone receptor antagonist on bone markers in acromegaly.
    Fairfield WP; Sesmilo G; Katznelson L; Pulaski K; Freda PU; Stavrou S; Kleinberg D; Klibanski A
    Clin Endocrinol (Oxf); 2002 Sep; 57(3):385-90. PubMed ID: 12201832
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential impact of glucose administered intravenously or orally on bone turnover markers in healthy male subjects.
    Westberg-Rasmussen S; Starup-Linde J; Hermansen K; Holst JJ; Hartmann B; Vestergaard P; Gregersen S
    Bone; 2017 Apr; 97():261-266. PubMed ID: 28126633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Denosumab in treatment-naïve and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers.
    Anastasilakis AD; Polyzos SA; Efstathiadou ZA; Savvidis M; Sakellariou GT; Papatheodorou A; Kokkoris P; Makras P
    Metabolism; 2015 Oct; 64(10):1291-7. PubMed ID: 26198440
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reference intervals in Danish children and adolescents for bone turnover markers carboxy-terminal cross-linked telopeptide of type I collagen (β-CTX), pro-collagen type I N-terminal propeptide (PINP), osteocalcin (OC) and bone-specific alkaline phosphatase (bone ALP).
    Diemar SS; Lylloff L; Rønne MS; Møllehave LT; Heidemann M; Thuesen BH; Johannesen J; Schou AJ; Husby S; Wedderkopp N; Mølgaard C; Jørgensen NR
    Bone; 2021 May; 146():115879. PubMed ID: 33561588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone turnover biomarkers and risk of osteoporotic hip fracture in an Asian population.
    Dai Z; Wang R; Ang LW; Yuan JM; Koh WP
    Bone; 2016 Feb; 83():171-177. PubMed ID: 26555636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.